Company intelligence / Profile preview

ScubaTx

Newcastle upon Tyne, United Kingdomscubatx.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

ScubaTx has developed a proprietary organ preservation platform that uses advanced temperature control and persufflation to keep organs cool and oxygenated during transport. The system is designed to extend organ viability beyond current static cold storage methods. The company is currently in pre-clinical development and has recently raised funding to accelerate its progress[3].

Therapeutic areas: Immunology
Modalities: Organ preservation devices (not therapeutics; device-based)
Industry: Therapeutic Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships disclosed; engaging with future commercial partners and key opinion leaders including in the US market.[3]

Beyond the preview

Go deeper on ScubaTx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ScubaTx.

Explore the full profile